Samenvatting
The cytokine interferon-alpha (IFN-α) is increasingly prescribed for a number of indications, especially viral hepatitis and several malignancies. Two patients are described who developed Raynaud's syndrome during treatment with IFN-α as adjuvant therapy for high-risk melanoma. With a review of the available literature the symptomatology, possible pathophysiologic mechanisms and treatment options are discussed.
Originele taal-2 | Engels |
---|---|
Pagina's (van-tot) | 1501-1502 |
Aantal pagina's | 2 |
Tijdschrift | Annals of Oncology |
Volume | 11 |
Nummer van het tijdschrift | 11 |
DOI's | |
Status | Gepubliceerd - 2000 |
Extern gepubliceerd | Ja |